Organ Regeneration
Liver and Kidney Regeneration
PreclinicalActive
Key Facts
About EVerZom
EVerZom is a pioneering, privately-held biotech developing exosome therapeutics for regenerative medicine. The company has built an integrated, patented platform covering cell sourcing, exosome generation, loading, and formulation, enabling a pipeline led by programs for Crohn's fistula and liver/kidney regeneration, currently in preclinical development. Backed by non-dilutive funding from the European EIC Accelerator, EVerZom is scaling its manufacturing and advancing towards clinical trials while seeking co-development partnerships to expand into other therapeutic areas.
View full company profile